Tradestie Institutional Equity Comparison Engine

SRTM vs BDRX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BDRX Overall Edge

BDRX Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SRTM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BDRX at N/M Forward P/E and 0.0% operating margin (-64.1% YoY). In options structure, SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SRTM N/M vs BDRX N/M Fwd P/E
Growth & Margin Winner BDRX
Op Margin N/A vs 0.0% ยท YoY N/A vs -64.1%
Momentum & Technical Winner BDRX
1Y -86.8% vs -51.4% ยท 52W Pos 2% vs 18%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SRTM US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap N/A
1M Return -80.4%
1Y Return -86.83%
Forward P/E N/M
Unified AI Score
47.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
BDRX NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$1.88
-6.02% 1D
Market Cap $1.0M
1M Return +352.9%
1Y Return -51.42%
Forward P/E N/M
Unified AI Score
36.0 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRTM -86.83% BDRX -51.42% Spread: +466.86 pp (BDRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SRTM TTM Op. Margin: N/A BDRX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs BDRX. Trailing 12-month operating profitability (SRTM N/A vs BDRX 0.0%) and valuation multiples (SRTM N/M vs BDRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRTM (2) vs BDRX (6)
Institutional Metric SRTM BDRX Criterion Row Winner
Market Capitalization Scale N/A $1.0M Larger Scale BDRX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -64.1% Higher Growth BDRX
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin BDRX
Net Profit Margin Profitability N/A 0.0% Higher Margin BDRX
Return on Equity (ROE) Capital Efficiency N/A -42.0% Higher ROE BDRX
52-Week Range Position Momentum 2% ($0โ€“$1) 18% ($0โ€“$9) Stronger Trend BDRX
Beta / 30D Volatility Risk Regime N/A 5.62ฮฒ ยท 2621% Vol Lower Realized Risk SRTM
Unified Institutional Score Composite Signal 47.6 / 100 (HOLD) 36.0 / 100 (SELL) Higher Composite SRTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRTM vs BDRX Buy Guide
SRTM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SRTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BDRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BDRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRTM nor BDRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.